Recent data indicate that moxibustion, when integrated with normal CHF treatments, surpasses conventional therapy alone in enhancing left ventricular ejection fraction (LVEF), serum BNP levels, cardiac function, and myocardial ATP levels, while also diminishing myocardial fibrosis (6). Here, NPPB is linked to congestive heart failure.